
Keywords: زمان بی حرکتی; AD; Alzheimer's disease; APP/PS1; amyloid precursor protein/presenilin 1; Aβ; β-amyloid; CNS; central nervous system; CTRL; control; EPM; elevated plus maze; FST; forced swimming test; GLP-1R; glucagon-like peptide-1 receptor; i.c.v.; intracerebrovent